# Regeneron Pharmaceuticals, Inc. (REGN) — Q2-2011 Earnings Results

**Report date:** 2011-07-28 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q2-2011

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Misses on EPS — Stock Down 0.04%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.69 | N/A | -67.88% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management conveyed a cautious outlook, recognizing the difficulties but maintaining a commitment to future strategies.

**Key quotes:**

> Management acknowledged the challenges faced during the quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No guidance data was provided during the call.

### What It Means

This earnings report indicates that Regeneron Pharmaceuticals faced significant challenges in the second quarter, particularly reflected in the negative EPS. The stock's slight decline of 0.04% suggests that investors are reacting cautiously to the missed expectations. Without any revenue figures or guidance, uncertainty remains about the company's near-term performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q2-2011_